IMCR
Immunocore Holdings Plc-adr
$51.31
Earnings Summary
Revenue | $47.76Mn |
Net Profits | $-14.08Mn |
Net Profit Margins | -29.47% |
Highlights
Immunocore Holdings Plc-adr’s revenue jumped 49.25% since last year same period to $47.76Mn in the Q2 2023. On a quarterly growth basis, Immunocore Holdings Plc-adr has generated 7.24% jump in its revenue since last 3-months.
Immunocore Holdings Plc-adr’s net profit fell -129.98% since last year same period to $-14.08Mn in the Q2 2023. On a quarterly growth basis, Immunocore Holdings Plc-adr has generated 15.69% jump in its net profits since last 3-months.
Immunocore Holdings Plc-adr’s net profit margin fell -54.09% since last year same period to -29.47% in the Q2 2023. On a quarterly growth basis, Immunocore Holdings Plc-adr has generated 21.38% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Immunocore Holdings Plc-adr post its latest quarter earnings
EPS Estimate Current Quarter | -0.36 |
EPS Estimate Current Year | -0.36 |
Highlights
Immunocore Holdings Plc-adr’s earning per share (EPS) estimates for the current quarter stand at -0.36 - a -22.51% fall from last quarter’s estimates.
Immunocore Holdings Plc-adr’s earning per share (EPS) estimates for the current year stand at -0.36.
Key Ratios
Key ratios of the Immunocore Holdings Plc-adr post its Q3 2023 earnings
Earning Per Share (EPS) | 0 |
Highlights
Immunocore Holdings Plc-adr’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2023. This indicates that the Immunocore Holdings Plc-adr has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-11-08 | -0.36 | 0 | 100% |
2023-06-30 | -0.29 | 0 | 100% |
₹0 US Stocks a/c Opening Fee